Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Vulvar Neoplasms 1Vaginal Neoplasms 1Papillomavirus Infections 1Atypical Squamous Cells of the Cervix 1

Interventions

Paclitaxel 581Carboplatin 528Cisplatin 359Bevacizumab 256pembrolizumab 228Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 128Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 91niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 74Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 57Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
High-Throughput Screening Assays × Gynecologic × Clear all
NCT01550783 2020-07-31

Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening

University of Washington

Phase NA Completed
1,335 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

NCT01313104 2012-06-11

Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer

Northwestern University

Phase NA Withdrawn
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡